CLBFX
Price
$37.18
Change
-$0.14 (-0.38%)
Updated
Aug 19 closing price
Net Assets
255.61B
MACHX
Price
$22.34
Change
-$0.07 (-0.31%)
Updated
Aug 19 closing price
Net Assets
208.09M
Interact to see
Advertisement

CLBFX vs MACHX

Header iconCLBFX vs MACHX Comparison
Open Charts CLBFX vs MACHXBanner chart's image
American Funds American Balanced 529F
Price$37.18
Change-$0.14 (-0.38%)
VolumeN/A
Net Assets255.61B
MoA Balanced Fund
Price$22.34
Change-$0.07 (-0.31%)
VolumeN/A
Net Assets208.09M
CLBFX vs MACHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CLBFX vs. MACHX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBFX is a Buy and MACHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 256B vs. MACHX (208M). MACHX (2.04) and CLBFX (1.97) have matching dividends . CLBFX was incepted earlier than MACHX: CLBFX (23 years) vs MACHX (41 years). CLBFX (0.67) is less costly to investors than MACHX (0.56). CLBFX is a more actively managed with annual turnover of: 44.00 vs. MACHX (36.98). CLBFX has a lower initial minimum investment than MACHX: CLBFX (250) vs MACHX (1000). MACHX annual gain was more profitable for investors over the last year : 7.47 vs. CLBFX (6.98). CLBFX return over 5 years is better than : 40.55 vs. MACHX (30.18).
CLBFXMACHXCLBFX / MACHX
Total Expense Ratio0.670.56120%
Annual Report Gross Expense Ratio0.670.56120%
Fund Existence23 years41 years-
Gain YTD9.43511.06585%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets256B208M123,077%
Annual Yield % from dividends1.972.0497%
Returns for 1 year6.987.4793%
Returns for 3 years32.2623.35138%
Returns for 5 years40.5530.18134%
Returns for 10 years88.4042.20209%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS8.820.05
+0.57%
Aligos Therapeutics Inc
SPOK17.960.01
+0.07%
Spok Holdings
CCIRU13.65N/A
N/A
Cohen Circle Acquisition Corp. I
VRNA105.56-0.23
-0.22%
Verona Pharma plc
DYN12.25-0.08
-0.65%
Dyne Therapeutics